|
|
|
|
|
|
by aquafox
412 days ago
|
|
|
I had a look at your trial description (https://clinicaltrials.gov/study/NCT06424912) Are you planning to publish the longitudinal data, esp. of endpoints 2 and 3 (prostate size, urinary flow). It would greatly add to the public understanding of this procedure. Why didn't you go for PSA? It's easy to obtain altough one probably wouldn't expect significant changes in this short time frame. |
|
|
We are collecting PSA data as well. It’s a useful parameter for prostate cancer.